欧洲农业中的农药风险评估:分布模式,禁用替代效应和监管影响
Luisa Gensch1, Kerstin Jantke2, Livia Rasche3
1Max Planck Institute for Meteorology, Hamburg, Germany; International Max Planck Research School on Earth System Modelling, Hamburg, Germany; Research Unit Sustainability and Climate Risks, University of Hamburg, Germany; Center for Earth System Research and Sustainability (CEN), University of Hamburg, Germany.
Environmental pollution (Barking, Essex : 1987)
|March 24, 2024
概括
最近的欧盟农药禁令可能会使农药负载减少94%,但可能会发生风险转移. 改善农药使用报告对于环境保护和非标生物安全至关重要.
科学领域:
- 环境科学 环境科学
- 农业科学 农业科学
- 生态毒理学 生态毒理学
背景情况:
- 农业农药对非目标生物和生态系统构成风险.
- 量化农药负载对于环境风险评估至关重要.
- 了解农药禁令的影响对于可持续农业至关重要.
研究的目的:
- 估计欧盟农业农药对环境的风险.
- 对28种作物和牧场的59种农药量化和绘制农药负载.
- 调查由于最近欧盟禁止农药的农药使用和负载的潜在减少.
主要方法:
- 结合了详细的农药应用数据 (2015) 与丹麦农药负载风险指标.
- 欧盟28种作物和牧场的59种农药的量化和绘制的农药负载.
- 评估了2018年至2023年期间实施的14种农药禁令的潜在影响.
主要成果:
- 在塞浦路斯和荷兰,每公农药含量最高.
- 在禁止之前,pyrifos对农药负载做出了重大贡献.
- 禁止14种农药可能会使农药负载减少94%,但保留了替代效应的警告.
结论:
- 禁止农药可以显著减少农药负载,但风险转移是一个问题.
- 当前的禁令可能无法完全减轻环境影响,如果不考虑替代效应.
- 加强关于农药使用的详细报告对于准确的风险评估和缓解策略至关重要.
相关概念视频
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
126
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
126
01:03Drug Control Governance: Regulatory Bodies and Their Impact
158
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
158